Ken Griffin Sol Gel Technologies Ltd. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Sol Gel Technologies Ltd. stock. As of the latest transaction made, Citadel Advisors LLC holds 5,400 shares of SLGL stock, worth $3,564. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,400
Previous 200
2600.0%
Holding current value
$3,564
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding SLGL
# of Institutions
22Shares Held
7.34MCall Options Held
5.4KPut Options Held
0-
Phoenix Holdings Ltd. Givatayim, L32.47MShares$1.63 Million0.04% of portfolio
-
Armistice Capital, LLC New York, NY2.03MShares$1.34 Million0.02% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.1.23MShares$810,1810.02% of portfolio
-
Harel Insurance Investments & Financial Services Ltd.920KShares$607,4190.02% of portfolio
-
Yelin Lapidot Holdings Management Ltd. Tel Aviv, L3229KShares$151,2570.04% of portfolio
About Sol-Gel Technologies Ltd.
- Ticker SLGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,129,500
- Market Cap $15.3M
- Description
- Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...